Bryan Bergman
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin Resistance | 48 | 2023 | 1072 | 8.110 |
Why?
| Muscle, Skeletal | 37 | 2023 | 1472 | 5.210 |
Why?
| Sphingolipids | 7 | 2023 | 57 | 2.760 |
Why?
| Diabetes Mellitus, Type 2 | 21 | 2023 | 2094 | 2.740 |
Why?
| Triglycerides | 15 | 2022 | 467 | 2.470 |
Why?
| Adipose Tissue | 16 | 2023 | 539 | 2.430 |
Why?
| Diglycerides | 7 | 2020 | 53 | 2.240 |
Why?
| Insulin | 25 | 2023 | 2076 | 1.910 |
Why?
| Blood Glucose | 28 | 2023 | 1819 | 1.890 |
Why?
| Exercise | 12 | 2020 | 1644 | 1.850 |
Why?
| Obesity | 29 | 2023 | 2507 | 1.840 |
Why?
| Physical Endurance | 12 | 2020 | 232 | 1.570 |
Why?
| Fasting | 6 | 2019 | 240 | 1.570 |
Why?
| Rest | 6 | 2017 | 103 | 1.240 |
Why?
| Liver | 12 | 2019 | 1634 | 1.220 |
Why?
| Glucose Clamp Technique | 19 | 2021 | 181 | 1.200 |
Why?
| Lipogenesis | 4 | 2017 | 56 | 1.140 |
Why?
| Fatty Acids, Nonesterified | 10 | 2022 | 151 | 1.060 |
Why?
| Prediabetic State | 5 | 2016 | 219 | 1.000 |
Why?
| Intra-Abdominal Fat | 4 | 2022 | 77 | 1.000 |
Why?
| Lipids | 4 | 2020 | 580 | 0.960 |
Why?
| Glucose | 9 | 2023 | 896 | 0.950 |
Why?
| Muscle Fibers, Skeletal | 4 | 2023 | 185 | 0.940 |
Why?
| Glucagon-Like Peptide 1 | 2 | 2023 | 101 | 0.910 |
Why?
| Receptors, Gastrointestinal Hormone | 1 | 2023 | 5 | 0.900 |
Why?
| Glucose Tolerance Test | 11 | 2021 | 343 | 0.890 |
Why?
| Lipid Metabolism | 11 | 2023 | 444 | 0.860 |
Why?
| Dietary Fats | 6 | 2020 | 287 | 0.830 |
Why?
| Diabetes Mellitus, Type 1 | 18 | 2019 | 3244 | 0.800 |
Why?
| Carnitine | 2 | 2021 | 62 | 0.770 |
Why?
| Athletes | 6 | 2020 | 328 | 0.700 |
Why?
| Humans | 79 | 2023 | 114623 | 0.660 |
Why?
| Tandem Mass Spectrometry | 3 | 2021 | 411 | 0.660 |
Why?
| Weight Loss | 2 | 2023 | 641 | 0.660 |
Why?
| Energy Metabolism | 4 | 2021 | 731 | 0.640 |
Why?
| Hypoglycemic Agents | 2 | 2023 | 1008 | 0.620 |
Why?
| Adult | 38 | 2021 | 30528 | 0.600 |
Why?
| Male | 57 | 2022 | 55554 | 0.590 |
Why?
| Glucose Intolerance | 4 | 2014 | 136 | 0.580 |
Why?
| Adipocytes | 2 | 2023 | 188 | 0.570 |
Why?
| Lactic Acid | 7 | 2009 | 275 | 0.570 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2019 | 470 | 0.560 |
Why?
| Female | 55 | 2023 | 59466 | 0.560 |
Why?
| Phosphatidylethanolamines | 2 | 2017 | 66 | 0.550 |
Why?
| Ceramides | 5 | 2023 | 91 | 0.550 |
Why?
| Choristoma | 1 | 2015 | 23 | 0.510 |
Why?
| Phosphatidylcholines | 1 | 2016 | 133 | 0.500 |
Why?
| Mitochondria, Muscle | 5 | 2021 | 93 | 0.500 |
Why?
| Hyperglycemia | 3 | 2014 | 291 | 0.450 |
Why?
| Smoking | 2 | 2012 | 1380 | 0.450 |
Why?
| Myocardium | 2 | 2009 | 913 | 0.450 |
Why?
| Benzhydryl Compounds | 1 | 2013 | 60 | 0.420 |
Why?
| Body Composition | 8 | 2021 | 590 | 0.420 |
Why?
| Phenols | 1 | 2013 | 82 | 0.420 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2012 | 47 | 0.410 |
Why?
| Atrial Function | 2 | 2009 | 11 | 0.410 |
Why?
| Homeostasis | 1 | 2016 | 573 | 0.410 |
Why?
| Culture Media, Conditioned | 2 | 2022 | 105 | 0.400 |
Why?
| Oxidation-Reduction | 7 | 2021 | 923 | 0.400 |
Why?
| Lipoprotein Lipase | 2 | 2015 | 54 | 0.390 |
Why?
| Physical Fitness | 4 | 2004 | 179 | 0.390 |
Why?
| Sleep | 3 | 2021 | 631 | 0.380 |
Why?
| Middle Aged | 24 | 2020 | 26719 | 0.380 |
Why?
| Glycerol | 5 | 2015 | 84 | 0.370 |
Why?
| Fatty Acids | 4 | 2023 | 381 | 0.360 |
Why?
| Incretins | 1 | 2010 | 15 | 0.360 |
Why?
| Subcutaneous Fat | 2 | 2022 | 70 | 0.350 |
Why?
| Sleep Deprivation | 3 | 2021 | 166 | 0.350 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2010 | 44 | 0.340 |
Why?
| Pyrazines | 1 | 2010 | 71 | 0.340 |
Why?
| Sarcolemma | 2 | 2020 | 29 | 0.330 |
Why?
| Triazoles | 1 | 2010 | 131 | 0.330 |
Why?
| Insulin-Secreting Cells | 2 | 2010 | 317 | 0.330 |
Why?
| Physical Education and Training | 2 | 1999 | 62 | 0.320 |
Why?
| Cytosol | 2 | 2020 | 208 | 0.320 |
Why?
| Cardiac Pacing, Artificial | 1 | 2009 | 77 | 0.310 |
Why?
| Animals | 25 | 2023 | 31694 | 0.300 |
Why?
| Cross-Sectional Studies | 6 | 2023 | 4405 | 0.300 |
Why?
| Thinness | 2 | 2007 | 87 | 0.290 |
Why?
| Endoplasmic Reticulum | 2 | 2020 | 234 | 0.280 |
Why?
| T-Lymphocytes | 5 | 2000 | 1736 | 0.280 |
Why?
| Pulmonary Gas Exchange | 3 | 2007 | 117 | 0.270 |
Why?
| Body Mass Index | 5 | 2018 | 1956 | 0.260 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2018 | 141 | 0.260 |
Why?
| Polycystic Ovary Syndrome | 2 | 2019 | 141 | 0.250 |
Why?
| Palmitates | 2 | 2018 | 16 | 0.250 |
Why?
| Young Adult | 11 | 2019 | 10455 | 0.250 |
Why?
| Islets of Langerhans | 5 | 2000 | 726 | 0.250 |
Why?
| Heart Rate | 1 | 2008 | 709 | 0.250 |
Why?
| Energy Intake | 3 | 2021 | 427 | 0.240 |
Why?
| Adiposity | 4 | 2022 | 457 | 0.240 |
Why?
| Prostatic Neoplasms | 3 | 2020 | 921 | 0.230 |
Why?
| Citric Acid Cycle | 2 | 2021 | 43 | 0.220 |
Why?
| Circadian Clocks | 1 | 2023 | 42 | 0.220 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 386 | 0.220 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 555 | 0.220 |
Why?
| Adiponectin | 3 | 2015 | 213 | 0.220 |
Why?
| Catecholamines | 1 | 2023 | 94 | 0.220 |
Why?
| Mitochondrial Diseases | 1 | 2023 | 77 | 0.210 |
Why?
| Fatty Liver | 2 | 2016 | 210 | 0.210 |
Why?
| Isophane Insulin, Human | 1 | 2022 | 5 | 0.210 |
Why?
| Oxygen Consumption | 4 | 2016 | 588 | 0.210 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2022 | 20 | 0.210 |
Why?
| Gluconeogenesis | 2 | 2018 | 62 | 0.210 |
Why?
| Sex Characteristics | 4 | 2021 | 640 | 0.210 |
Why?
| Case-Control Studies | 5 | 2019 | 3003 | 0.200 |
Why?
| Adipokines | 1 | 2022 | 42 | 0.200 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.200 |
Why?
| Blotting, Western | 3 | 2016 | 1147 | 0.200 |
Why?
| Biopsy | 3 | 2018 | 1036 | 0.200 |
Why?
| Interleukin-13 | 1 | 2022 | 122 | 0.200 |
Why?
| Dinoprostone | 1 | 2022 | 184 | 0.200 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2023 | 198 | 0.200 |
Why?
| Histone Deacetylases | 1 | 2023 | 195 | 0.200 |
Why?
| Subcellular Fractions | 2 | 2021 | 78 | 0.200 |
Why?
| Paracrine Communication | 1 | 2022 | 56 | 0.190 |
Why?
| Exercise Test | 5 | 2015 | 544 | 0.190 |
Why?
| Bone Marrow | 1 | 2023 | 243 | 0.190 |
Why?
| Stearoyl-CoA Desaturase | 3 | 2012 | 53 | 0.190 |
Why?
| Interleukin-8 | 1 | 2022 | 237 | 0.190 |
Why?
| Lipolysis | 2 | 2018 | 39 | 0.190 |
Why?
| Bone Remodeling | 1 | 2021 | 65 | 0.180 |
Why?
| Knee | 1 | 2001 | 51 | 0.180 |
Why?
| Diabetic Angiopathies | 3 | 2011 | 244 | 0.180 |
Why?
| Electric Stimulation | 1 | 2001 | 250 | 0.170 |
Why?
| Immunity | 1 | 2020 | 121 | 0.170 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 343 | 0.170 |
Why?
| Diabetic Neuropathies | 1 | 2021 | 79 | 0.170 |
Why?
| Antigens, Surface | 1 | 2000 | 146 | 0.170 |
Why?
| Hyperinsulinism | 2 | 2019 | 103 | 0.170 |
Why?
| Autophagy-Related Proteins | 2 | 2017 | 39 | 0.170 |
Why?
| Palmitic Acid | 2 | 2010 | 36 | 0.170 |
Why?
| Autoantigens | 2 | 2000 | 396 | 0.160 |
Why?
| Calorimetry, Indirect | 3 | 2019 | 69 | 0.160 |
Why?
| Interleukin-6 | 1 | 2022 | 676 | 0.160 |
Why?
| Guanosine Triphosphate | 1 | 2018 | 85 | 0.160 |
Why?
| Obesity, Abdominal | 1 | 2018 | 37 | 0.160 |
Why?
| Rats | 3 | 2022 | 4958 | 0.160 |
Why?
| rac1 GTP-Binding Protein | 1 | 2018 | 56 | 0.150 |
Why?
| Kinetics | 6 | 2006 | 1551 | 0.150 |
Why?
| Primary Cell Culture | 1 | 2019 | 149 | 0.150 |
Why?
| Cohort Studies | 5 | 2021 | 4894 | 0.150 |
Why?
| Diet | 4 | 2013 | 1080 | 0.150 |
Why?
| Basal Metabolism | 2 | 2008 | 46 | 0.150 |
Why?
| Metabolic Syndrome | 2 | 2013 | 321 | 0.150 |
Why?
| Muscle Contraction | 1 | 2001 | 389 | 0.150 |
Why?
| Cell Nucleus | 1 | 2020 | 554 | 0.150 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 245 | 0.150 |
Why?
| Diet, Western | 3 | 2023 | 66 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1139 | 0.140 |
Why?
| Metabolomics | 3 | 2019 | 521 | 0.140 |
Why?
| Autophagy-Related Protein-1 Homolog | 1 | 2017 | 6 | 0.140 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2017 | 45 | 0.140 |
Why?
| Mice | 12 | 2023 | 14860 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 385 | 0.140 |
Why?
| Biological Transport | 1 | 2017 | 373 | 0.130 |
Why?
| Gene Expression Profiling | 2 | 2023 | 1518 | 0.130 |
Why?
| Phosphorylation | 4 | 2015 | 1569 | 0.130 |
Why?
| Biomarkers | 4 | 2023 | 3408 | 0.130 |
Why?
| Circadian Rhythm | 1 | 2019 | 354 | 0.130 |
Why?
| Metformin | 1 | 2019 | 276 | 0.130 |
Why?
| Weight Gain | 1 | 2019 | 453 | 0.130 |
Why?
| Microtubule-Associated Proteins | 1 | 2017 | 174 | 0.130 |
Why?
| Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.130 |
Why?
| Mitochondria | 2 | 2018 | 747 | 0.130 |
Why?
| Amino Acids | 1 | 2019 | 448 | 0.120 |
Why?
| Insulin Receptor Substrate Proteins | 2 | 2012 | 56 | 0.120 |
Why?
| Insulinoma | 2 | 1999 | 29 | 0.120 |
Why?
| Algorithms | 3 | 2015 | 1466 | 0.120 |
Why?
| Pain | 1 | 2001 | 705 | 0.120 |
Why?
| Oxygen | 2 | 2015 | 854 | 0.120 |
Why?
| Coronary Artery Disease | 2 | 2011 | 607 | 0.120 |
Why?
| RNA, Messenger | 3 | 2014 | 2552 | 0.120 |
Why?
| Cell Hypoxia | 1 | 2015 | 220 | 0.120 |
Why?
| Pregnancy | 6 | 2023 | 5517 | 0.120 |
Why?
| Receptors, AMPA | 1 | 2015 | 119 | 0.120 |
Why?
| Adolescent | 11 | 2023 | 17831 | 0.120 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 531 | 0.120 |
Why?
| Extracellular Vesicles | 1 | 2015 | 83 | 0.120 |
Why?
| Somatostatin | 1 | 2014 | 52 | 0.110 |
Why?
| Neurodegenerative Diseases | 1 | 2015 | 92 | 0.110 |
Why?
| Fetal Development | 1 | 2016 | 246 | 0.110 |
Why?
| Cytoplasmic Granules | 1 | 1994 | 82 | 0.110 |
Why?
| Fructose | 1 | 2014 | 100 | 0.110 |
Why?
| Regression Analysis | 1 | 2016 | 944 | 0.110 |
Why?
| Leg | 3 | 1999 | 225 | 0.110 |
Why?
| Clone Cells | 4 | 2000 | 247 | 0.110 |
Why?
| Antigens, Neoplasm | 2 | 1994 | 221 | 0.110 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 452 | 0.110 |
Why?
| Medroxyprogesterone Acetate | 1 | 2012 | 28 | 0.100 |
Why?
| Macaca | 3 | 2018 | 50 | 0.100 |
Why?
| Myocardial Reperfusion Injury | 1 | 2013 | 95 | 0.100 |
Why?
| Hypoxia | 1 | 2018 | 957 | 0.100 |
Why?
| Phospholipids | 2 | 2012 | 197 | 0.100 |
Why?
| Taxoids | 1 | 2012 | 93 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2019 | 2319 | 0.100 |
Why?
| Cholesterol | 2 | 2013 | 367 | 0.100 |
Why?
| Progestins | 1 | 2012 | 75 | 0.100 |
Why?
| Coronary Vessels | 2 | 2010 | 227 | 0.100 |
Why?
| Hemodynamics | 3 | 2008 | 1012 | 0.100 |
Why?
| Absorptiometry, Photon | 3 | 2019 | 224 | 0.100 |
Why?
| Recovery of Function | 1 | 2015 | 574 | 0.100 |
Why?
| Myocardial Contraction | 1 | 2013 | 313 | 0.090 |
Why?
| Reference Values | 2 | 2010 | 742 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1796 | 0.090 |
Why?
| Estradiol | 2 | 2019 | 455 | 0.090 |
Why?
| Fenofibrate | 1 | 2011 | 24 | 0.090 |
Why?
| Sitagliptin Phosphate | 1 | 2010 | 30 | 0.090 |
Why?
| Hypolipidemic Agents | 1 | 2011 | 86 | 0.090 |
Why?
| Mice, Inbred C57BL | 2 | 2023 | 4689 | 0.090 |
Why?
| Nicotine | 1 | 2012 | 265 | 0.090 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2012 | 358 | 0.080 |
Why?
| C-Peptide | 1 | 2010 | 138 | 0.080 |
Why?
| Retinoid X Receptor gamma | 1 | 2009 | 4 | 0.080 |
Why?
| PPAR alpha | 1 | 2009 | 52 | 0.080 |
Why?
| Metabolic Clearance Rate | 2 | 2006 | 102 | 0.080 |
Why?
| Bicycling | 1 | 2010 | 86 | 0.080 |
Why?
| Lipoproteins | 1 | 2010 | 159 | 0.080 |
Why?
| Expiratory Reserve Volume | 1 | 2008 | 1 | 0.080 |
Why?
| Gene Expression | 3 | 2023 | 1421 | 0.080 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 923 | 0.080 |
Why?
| Signal Transduction | 4 | 2018 | 4509 | 0.080 |
Why?
| Calcinosis | 1 | 2011 | 242 | 0.080 |
Why?
| Coronary Circulation | 1 | 2008 | 133 | 0.080 |
Why?
| Pancreatic Neoplasms | 2 | 1999 | 731 | 0.080 |
Why?
| Drug Resistance, Neoplasm | 1 | 2012 | 636 | 0.080 |
Why?
| Calcium | 2 | 2010 | 1104 | 0.080 |
Why?
| Ethinyl Estradiol | 1 | 1988 | 17 | 0.080 |
Why?
| Arteries | 2 | 2000 | 247 | 0.070 |
Why?
| Cardiovascular Diseases | 3 | 2018 | 1727 | 0.070 |
Why?
| Regional Blood Flow | 2 | 1999 | 424 | 0.070 |
Why?
| Receptor, Insulin | 1 | 2007 | 93 | 0.070 |
Why?
| Overweight | 1 | 2011 | 471 | 0.070 |
Why?
| Hyperphagia | 1 | 2006 | 28 | 0.070 |
Why?
| Adaptation, Physiological | 1 | 2010 | 483 | 0.070 |
Why?
| Child | 7 | 2019 | 18404 | 0.070 |
Why?
| Sex Factors | 4 | 2018 | 1715 | 0.070 |
Why?
| Heart | 1 | 2009 | 612 | 0.060 |
Why?
| Substance Withdrawal Syndrome | 1 | 1988 | 159 | 0.060 |
Why?
| Sex Hormone-Binding Globulin | 2 | 2019 | 48 | 0.060 |
Why?
| Metabolome | 2 | 2019 | 282 | 0.060 |
Why?
| ARNTL Transcription Factors | 1 | 2023 | 13 | 0.060 |
Why?
| Ubiquinone | 1 | 2023 | 21 | 0.060 |
Why?
| Pyruvic Acid | 1 | 2004 | 42 | 0.060 |
Why?
| Uncoupling Protein 1 | 1 | 2023 | 15 | 0.060 |
Why?
| Electron Transport | 1 | 2023 | 108 | 0.060 |
Why?
| Thermogenesis | 1 | 2023 | 37 | 0.050 |
Why?
| Adipose Tissue, Brown | 1 | 2023 | 43 | 0.050 |
Why?
| Carbohydrate Metabolism | 2 | 2004 | 48 | 0.050 |
Why?
| Neoplasms | 1 | 2017 | 2097 | 0.050 |
Why?
| Cell Line | 4 | 2018 | 2635 | 0.050 |
Why?
| Prognosis | 2 | 2023 | 3328 | 0.050 |
Why?
| Physical Exertion | 1 | 2004 | 209 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2010 | 2537 | 0.050 |
Why?
| Insulin, Regular, Human | 1 | 2022 | 33 | 0.050 |
Why?
| Time Factors | 2 | 2010 | 6112 | 0.050 |
Why?
| Protein Binding | 2 | 2018 | 1889 | 0.050 |
Why?
| Diet, High-Fat | 1 | 2023 | 225 | 0.050 |
Why?
| Body Weight | 1 | 2006 | 868 | 0.050 |
Why?
| Primates | 1 | 2023 | 111 | 0.050 |
Why?
| Aged | 5 | 2011 | 19061 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 2012 | 1879 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 1947 | 0.050 |
Why?
| Oxidative Stress | 2 | 2018 | 1076 | 0.050 |
Why?
| Osteocalcin | 1 | 2021 | 34 | 0.050 |
Why?
| Adenocarcinoma | 1 | 1988 | 795 | 0.050 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2015 | 160 | 0.050 |
Why?
| Swine, Miniature | 2 | 2013 | 71 | 0.050 |
Why?
| Proteins | 2 | 2015 | 908 | 0.050 |
Why?
| Testosterone | 2 | 2019 | 343 | 0.050 |
Why?
| Ranolazine | 1 | 2020 | 22 | 0.050 |
Why?
| Torque | 1 | 2001 | 66 | 0.050 |
Why?
| Collagen Type I | 1 | 2021 | 108 | 0.050 |
Why?
| Electrodes | 1 | 2001 | 100 | 0.040 |
Why?
| Chromatography, Ion Exchange | 1 | 2000 | 48 | 0.040 |
Why?
| Cytotoxicity, Immunologic | 1 | 2020 | 195 | 0.040 |
Why?
| Detergents | 1 | 2000 | 41 | 0.040 |
Why?
| Serine | 1 | 2021 | 126 | 0.040 |
Why?
| Chromatography, Gel | 1 | 2000 | 122 | 0.040 |
Why?
| Infant | 2 | 2023 | 7959 | 0.040 |
Why?
| L-Lactate Dehydrogenase | 1 | 2000 | 107 | 0.040 |
Why?
| Tumor Burden | 1 | 2020 | 259 | 0.040 |
Why?
| Solubility | 1 | 2000 | 223 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 318 | 0.040 |
Why?
| Cell Membrane | 2 | 2000 | 680 | 0.040 |
Why?
| Isometric Contraction | 1 | 2001 | 155 | 0.040 |
Why?
| Mice, SCID | 1 | 2000 | 314 | 0.040 |
Why?
| Glycogen | 1 | 1999 | 51 | 0.040 |
Why?
| Disease Models, Animal | 3 | 2015 | 3531 | 0.040 |
Why?
| Pilot Projects | 1 | 2023 | 1372 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 398 | 0.040 |
Why?
| Eating | 1 | 2021 | 344 | 0.040 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2000 | 170 | 0.040 |
Why?
| Glucagon | 1 | 1999 | 92 | 0.040 |
Why?
| Swine | 2 | 2013 | 700 | 0.040 |
Why?
| Glucose Transporter Type 4 | 1 | 2018 | 36 | 0.040 |
Why?
| Osmolar Concentration | 1 | 1999 | 173 | 0.040 |
Why?
| Postprandial Period | 1 | 1999 | 87 | 0.040 |
Why?
| Perception | 1 | 2001 | 311 | 0.040 |
Why?
| Muscle Proteins | 1 | 2000 | 210 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2020 | 347 | 0.040 |
Why?
| Dendritic Cells | 1 | 2020 | 435 | 0.040 |
Why?
| Immunity, Innate | 1 | 2023 | 720 | 0.040 |
Why?
| Cell Line, Tumor | 2 | 2015 | 2710 | 0.040 |
Why?
| Carbon Dioxide | 1 | 1999 | 218 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 335 | 0.030 |
Why?
| Cell Proliferation | 2 | 2015 | 2186 | 0.030 |
Why?
| Nutritional Status | 1 | 1999 | 287 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2017 | 91 | 0.030 |
Why?
| Carrier Proteins | 1 | 2000 | 695 | 0.030 |
Why?
| Prospective Studies | 2 | 2018 | 6217 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2020 | 687 | 0.030 |
Why?
| Deuterium | 1 | 2015 | 79 | 0.030 |
Why?
| Waist Circumference | 1 | 2015 | 122 | 0.030 |
Why?
| HeLa Cells | 1 | 2017 | 562 | 0.030 |
Why?
| Double-Blind Method | 1 | 2019 | 1660 | 0.030 |
Why?
| Androgens | 1 | 2016 | 167 | 0.030 |
Why?
| Lymphocyte Activation | 3 | 1994 | 1037 | 0.030 |
Why?
| Epitopes | 1 | 1997 | 435 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2020 | 1040 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 233 | 0.030 |
Why?
| Protein Subunits | 1 | 2015 | 201 | 0.030 |
Why?
| Membrane Proteins | 1 | 2000 | 1018 | 0.030 |
Why?
| Centrifugation, Density Gradient | 1 | 1994 | 40 | 0.030 |
Why?
| Culture Techniques | 1 | 1994 | 78 | 0.030 |
Why?
| Cell Fractionation | 1 | 1994 | 51 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1997 | 339 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 442 | 0.030 |
Why?
| Animal Feed | 1 | 2014 | 49 | 0.030 |
Why?
| Risk Factors | 3 | 2012 | 8628 | 0.030 |
Why?
| Memory | 1 | 2015 | 211 | 0.030 |
Why?
| Prevalence | 1 | 2019 | 2249 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 1994 | 396 | 0.030 |
Why?
| Amyloid beta-Peptides | 1 | 2015 | 189 | 0.030 |
Why?
| Acyl Coenzyme A | 1 | 2013 | 30 | 0.030 |
Why?
| Macrophage Activation | 1 | 2014 | 164 | 0.030 |
Why?
| Heart Function Tests | 1 | 2013 | 58 | 0.030 |
Why?
| Gonanes | 1 | 2012 | 27 | 0.030 |
Why?
| Fetus | 1 | 2016 | 699 | 0.030 |
Why?
| Cardiolipins | 1 | 2013 | 71 | 0.030 |
Why?
| Anaerobic Threshold | 2 | 2004 | 22 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2015 | 380 | 0.030 |
Why?
| Behavior, Animal | 1 | 2015 | 458 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 1994 | 849 | 0.020 |
Why?
| Models, Theoretical | 1 | 2015 | 515 | 0.020 |
Why?
| Models, Statistical | 1 | 2015 | 599 | 0.020 |
Why?
| Antigen-Presenting Cells | 1 | 1992 | 150 | 0.020 |
Why?
| Abdominal Fat | 1 | 2012 | 39 | 0.020 |
Why?
| Learning | 1 | 2015 | 350 | 0.020 |
Why?
| Molecular Weight | 1 | 2012 | 331 | 0.020 |
Why?
| Tomography, X-Ray Computed | 2 | 2010 | 2279 | 0.020 |
Why?
| Cognition Disorders | 1 | 2015 | 476 | 0.020 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 276 | 0.020 |
Why?
| Hippocampus | 1 | 2015 | 693 | 0.020 |
Why?
| Genotype | 1 | 2015 | 1760 | 0.020 |
Why?
| Receptors, Progesterone | 1 | 2012 | 319 | 0.020 |
Why?
| Abdomen | 1 | 2010 | 99 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2011 | 183 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2018 | 4411 | 0.020 |
Why?
| Sex Distribution | 1 | 2010 | 337 | 0.020 |
Why?
| Mice, Knockout | 1 | 2015 | 2565 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 493 | 0.020 |
Why?
| Environmental Monitoring | 1 | 2010 | 254 | 0.020 |
Why?
| Spleen | 1 | 2010 | 487 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2010 | 347 | 0.020 |
Why?
| Leydig Cells | 1 | 1988 | 11 | 0.020 |
Why?
| Gonadotropins, Pituitary | 1 | 1988 | 22 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2362 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2018 | 3039 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 329 | 0.020 |
Why?
| B-Lymphocytes | 1 | 1992 | 766 | 0.020 |
Why?
| Macrophages | 1 | 2014 | 1261 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 1840 | 0.020 |
Why?
| Patient Selection | 1 | 2010 | 641 | 0.020 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 373 | 0.020 |
Why?
| Amino Acid Sequence | 2 | 2000 | 1982 | 0.020 |
Why?
| Age Factors | 1 | 2012 | 2894 | 0.010 |
Why?
| Molecular Sequence Data | 2 | 2000 | 2785 | 0.010 |
Why?
| Femoral Vein | 1 | 2004 | 28 | 0.010 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2004 | 124 | 0.010 |
Why?
| Alanine | 1 | 2004 | 104 | 0.010 |
Why?
| Inflammation | 1 | 2014 | 2477 | 0.010 |
Why?
| Hormones | 1 | 2004 | 132 | 0.010 |
Why?
| Blood Pressure | 1 | 2009 | 1538 | 0.010 |
Why?
| Glycolysis | 1 | 2004 | 226 | 0.010 |
Why?
| Femoral Artery | 1 | 2004 | 167 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 2010 | 900 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2012 | 1862 | 0.010 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2000 | 20 | 0.010 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 58 | 0.010 |
Why?
| Glucose-6-Phosphatase | 1 | 1999 | 31 | 0.010 |
Why?
| Isoenzymes | 1 | 2000 | 283 | 0.010 |
Why?
| Mice, Obese | 1 | 1999 | 53 | 0.010 |
Why?
| Myosin Heavy Chains | 1 | 2000 | 177 | 0.010 |
Why?
| Fishes | 1 | 1999 | 80 | 0.010 |
Why?
| Open Reading Frames | 1 | 1999 | 116 | 0.010 |
Why?
| Conserved Sequence | 1 | 1999 | 218 | 0.010 |
Why?
| Sequence Alignment | 1 | 1999 | 323 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 353 | 0.010 |
Why?
| Exons | 1 | 1999 | 302 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 1999 | 325 | 0.010 |
Why?
| Dogs | 1 | 1999 | 334 | 0.010 |
Why?
| Cloning, Molecular | 1 | 1999 | 522 | 0.010 |
Why?
| Alternative Splicing | 1 | 1999 | 187 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1999 | 1143 | 0.010 |
Why?
| Base Sequence | 1 | 1999 | 2114 | 0.010 |
Why?
| Models, Molecular | 1 | 1999 | 1369 | 0.010 |
Why?
| Genetic Variation | 1 | 1999 | 870 | 0.010 |
Why?
| Trinitrobenzenes | 1 | 1992 | 13 | 0.010 |
Why?
| Adenoma, Islet Cell | 1 | 1992 | 10 | 0.010 |
Why?
| Haptens | 1 | 1992 | 21 | 0.010 |
Why?
| Hybrid Cells | 1 | 1992 | 49 | 0.010 |
Why?
| Ovalbumin | 1 | 1992 | 161 | 0.010 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1992 | 107 | 0.010 |
Why?
| Interleukin-2 | 1 | 1992 | 413 | 0.010 |
Why?
| Islets of Langerhans Transplantation | 1 | 1989 | 53 | 0.010 |
Why?
| Mice, Mutant Strains | 1 | 1989 | 271 | 0.010 |
Why?
| Pituitary Gland | 1 | 1989 | 148 | 0.000 |
Why?
|
|
Bergman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|